Deltacortril

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Deltacortril

Property Description
Active Ingredient Prednisolone (as Prednisolone Acetate)
Form Tablet or Enteric-Coated Tablet
Pharmacological Class Corticosteroid (Glucocorticoid)
General Purpose Systemic Anti-inflammatory and Immunosuppressant
Origin Synthetic

What Type of Medicine is Deltacortril?

Deltacortril is a prescription-only synthetic steroid medicine that belongs to the Corticosteroid class, specifically categorized as a Glucocorticoid. This compound is a human-made analogue of the hormones naturally produced by the adrenal glands, which are crucial for regulating the body’s inflammatory and immune activity. Prednisolone is a medication used for its ability to manage inflammatory and autoimmune diseases. Understanding that Deltacortril is a glucocorticoid confirms that it is a potent, systemic medication designed to address widespread inflammation and immune dysfunction.


Active Ingredient and Available Form

The core active ingredient in Deltacortril is Prednisolone, often administered as the ester Prednisolone Acetate, classifying it as a single active ingredient product. The medication is taken via the oral route of administration, available primarily as a standard tablet or an enteric-coated tablet. This enteric-coated form is a differentiating feature, designed with a specialized gastro-resistant layer that prevents the active ingredient from dissolving in the stomach, ensuring delayed release and reliable absorption once it reaches the small intestine. The gastro-resistant property serves to protect the active substance from the acidic environment of the stomach.


General Purpose of the Glucocorticoid Action

The fundamental purpose of Deltacortril's active substance is to function as a powerful anti-inflammatory agent and a systemic immunosuppressant. By modulating key cellular pathways, the drug effectively dampens the body’s inflammatory response, reducing the processes that cause swelling and tissue damage. This dual mechanism means the primary therapeutic goal of this medication is to rapidly and effectively minimize significant, widespread inflammation and curtail excessive activity in the immune system, providing broad systemic relief, such as in the management of severe allergic reactions. Systemic corticosteroids are utilized for these clinical purposes.

Regulatory References

  1. National Institutes of Health
  2. clinically recognized
  3. glucocorticoid
  4. anti-inflammatory agent
  5. immunosuppressant

What side effects are possible with Deltacortril?

Deltacortril (prednisolone), as a systemic glucocorticoid, has a regulatory safety profile that lists adverse reactions across multiple organ systems due to its broad physiological effects. The safety information is structured by frequency and organ class, as defined in official regulatory documents.

Adverse Reaction Scope

Common Adverse Reactions

The most frequently reported adverse reactions listed in regulatory documents include fluid retention, weight gain, elevation in blood pressure (hypertension), increased appetite, and behavioral or mood changes (e.g., euphoria, insomnia).

System-Organ Classes Involved

Adverse effects are formally categorized in domains such as Metabolism and Nutrition (e.g., altered glucose tolerance, hypokalemic alkalosis), Endocrine (e.g., HPA axis suppression, Cushingoid state), Musculoskeletal (e.g., osteoporosis, muscle weakness), Psychiatric (e.g., severe depression, psychosis), and Gastrointestinal (e.g., peptic ulceration, pancreatitis).

Serious Adverse Reactions

Official labels detail serious risks, including peptic ulcer with possible perforation and hemorrhage, acute adrenocortical insufficiency (following abrupt cessation of prolonged use), and increased vulnerability to severe systemic infections (e.g., fungal, bacterial), which may be masked. Increased intracranial pressure (pseudotumor cerebri) usually occurs following treatment discontinuation.

Safety Considerations

Duration- and Population-Related Patterns

  • Long-term exposure is associated with risks such as decreased bone density, cataracts, and the development of a Cushingoid state.
  • For children, prolonged use is specifically noted to cause suppression of growth and bone problems.
  • The drug should not be used in patients with systemic fungal infections or a known hypersensitivity. Patients on immunosuppressant doses must avoid live vaccines.

This structured safety profile establishes the systemic and multi-organ nature of potential risks, allowing for clear differentiation between common, expected effects and less frequent but critical safety concerns based on official governmental documentation.

Overdose and Emergency Response

Overdose and When to Seek Help

The information in this section is based on official government regulatory documents (e.g., FDA, EMA SmPC) concerning the overdose profile of Deltacortril (prednisolone).

Overdose Manifestations and Risks

Unlike many medicines, a single acute overdose of Deltacortril is generally reported in regulatory documents as unlikely to result in immediate, life-threatening toxic effects and may cause minor or no symptoms.

However, the primary risk associated with overexposure is chronic overdosage, which involves prolonged use of high doses. This can lead to serious systemic effects, including:

  • Hypercorticism (Cushingoid Features): Physical signs resulting from excess corticosteroid levels.
  • Exacerbation of Conditions: Worsening of pre-existing high blood pressure (hypertension) or diabetes (hyperglycemia).
  • Adrenocortical Insufficiency: A life-threatening endocrine condition that can occur if chronic high-dose therapy is stopped too abruptly.

Emergency Actions and Monitoring

No specific antidote for Deltacortril overdose is officially documented. Management requires supportive and symptomatic treatment, alongside close monitoring.

Immediate medical help is required in the following circumstances:

  1. Suspected Acute Overdose: Contact a poison control center or seek urgent medical care, even if the patient appears well.
  2. Symptoms of Adrenocortical Insufficiency: Seek immediate help if signs of adrenal crisis develop, particularly during or following the reduction or cessation of high-dose treatment. This is considered the most severe, life-threatening risk associated with inappropriate overexposure.

Monitoring requirements include observation of fluid status, blood pressure, and key lab values, such as serum electrolytes and blood glucose levels.

Therapeutic Uses of Deltacortril

What Deltacortril Treats: Main Uses and Benefits

Deltacortril is a brand name for the corticosteroid medicine prednisolone. It is applied in addressing symptoms related to physical discomfort and systemic imbalance that result from inflammatory or irritative states. It is applied across domains where additional symptomatic support is needed.

The medicine is commonly used across conditions presenting with acute episodes. Its indications include rheumatic disorders, allergic states, respiratory diseases, gastrointestinal diseases, dermatologic, ophthalmic, blood, and endocrine disorders. The drug is often used during phases when symptoms become more noticeable, such as acute or disruptive episodes.

In situations involving inflammatory or irritative states, Deltacortril provides supportive relief when symptoms interfere with routine activities. It supports patients during episodes of heightened discomfort.

“The medication helps address symptom clusters that may become intense or disruptive. It helps improve day-to-day comfort during symptomatic periods.”

Quick Fact: Relief for Symptoms of Increased Physiological Strain

Eligibility and Restrictions for Use

Who Can and Cannot Use Deltacortril?

Regulatory documentation defines strict eligibility rules for Deltacortril (prednisolone) based on population characteristics and underlying medical status.

Contraindications (Must Not Use)

Condition/Status Regulatory Rule
Systemic Fungal Infection Contraindicated in patients with an untreated condition.
Hypersensitivity Contraindicated if there is a known allergy to prednisolone or formulation components.
Live Vaccines Prohibited for individuals on high-dose therapy requiring live vaccines.

Restricted or Conditional Use

Use is permitted but requires caution and frequent monitoring in several patient populations:

  • Organ Function: Patients with renal insufficiency or liver failure (cirrhosis) due to altered drug effects.
  • Life Stage: Pregnant and lactating women face restricted use; treatment is contingent on a risk/benefit assessment and requires infant monitoring during breastfeeding.
  • Age Groups: Pediatric patients on prolonged therapy require careful monitoring of growth and development. Older adults require caution due to increased risk of side effects.
  • Comorbidities: Caution is mandatory for patients with conditions such as Diabetes Mellitus, active peptic ulceration, tuberculosis, and congestive heart failure.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Deltacortril (prednisolone) interacts with several classes of medicinal products, primarily through effects on metabolism or by combining effects that increase the risk of adverse events. Because Deltacortril is metabolized by the CYP3A4 enzyme system, medicines that affect this enzyme can alter its concentration in the body.

Interacting Drugs and Effects:

  • CYP3A4 Inducers (e.g., rifampin, phenytoin): These can increase the clearance of Deltacortril, potentially reducing its therapeutic effect. A higher Deltacortril dose may be required.
  • CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir): These can decrease the clearance of Deltacortril, potentially increasing the risk of side effects. A lower Deltacortril dose may be needed.
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including aspirin: Concomitant use increases the risk of gastrointestinal ulcers and bleeding.
  • Antidiabetic Agents (e.g., insulin, oral hypoglycemics): Deltacortril can increase blood glucose levels, requiring dose adjustment of the antidiabetic medication.
  • Potassium-Depleting Diuretics (e.g., Amphotericin B): Combined use may lead to severe hypokalemia (low potassium).
  • Cyclosporine: Use with Deltacortril can increase the activity of both drugs and has been associated with reports of convulsions.

Vaccination Restrictions:

Patients receiving immunosuppressive doses of corticosteroids should not be administered live or live attenuated vaccines due to the risk of vaccine-related infection.

Mechanism of Action

Deltacortril (Prednisolone) exerts its physiological effects by engaging specific intracellular receptors to modulate two primary biological systems: gene expression and inflammatory cascades.


Modulation of Gene Expression via the Glucocorticoid Receptor

The drug acts as an agonist by binding to the ubiquitous Glucocorticoid Receptor (GR) within cells. This binding initiates a dual mechanism: transactivation switches on genes for anti-inflammatory proteins (like Lipocortin-1), while transrepression physically blocks pro-inflammatory transcription factors (NF-κB, AP-1). This deep molecular intervention systematically limits the cell's ability to produce chemical signals that drive heightened immune and inflammatory responses.


Systemic Suppression of Inflammatory Mediators

The resulting upregulation of Lipocortin-1 indirectly inhibits Phospholipase A2 (PLA2), thereby arresting the key initial steps of the Arachidonic Acid Cascade and preventing the synthesis of key mediators like prostaglandins and leukotrienes. This comprehensive blockade leads to a functional stabilization of blood vessels and a reduction in capillary permeability, limiting the resulting fluid leakage and cellular migration associated with pathway activation.

Dosage and Administration Information

The administration of Deltacortril (prednisolone) follows a protocol that establishes the route, dose, and duration patterns. It is an oral medication, available as standard or enteric-coated tablets.

Administration Scope

Instruction Entity Administration Details
Route of Administration Oral. Tablets must be swallowed.
Dosing Schedule Highly individualized; initial daily doses generally range from 5 mg to 60 mg. The lowest effective dose is subsequently sought for maintenance.
Frequency and Timing Typically a single daily dose taken in the morning (before 9 A.M.) to align with the body's natural diurnal rhythm. Divided doses may be used for specific needs.
Timing in relation to meals Recommended to be taken with or immediately after food or milk to help minimize gastric irritation.
Preparation Requirements Enteric-coated tablets must be swallowed whole and should not be broken, crushed, or chewed, as this compromises the coating designed for delayed release.
Missed-Dose Rules If a dose is missed, it should be taken as soon as it is remembered. If it is almost time for the next dose, the missed dose should be skipped; doses must not be doubled to compensate.
Special Procedural Conditions Following prolonged therapy, the medication must be gradually reduced (tapered) according to a schedule. Abrupt discontinuation of the medicine after extended use is avoided.

Resulting Procedural Structure

The medicine is administered via the oral route, usually as a single dose in the morning, taken with food. The dose is initiated within a broad range and is subsequently subject to gradual reduction. For long-term use, the process involves a controlled tapering process when ending therapy, which is a standard administrative constraint of this medication.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Clinical Research

Studies have evaluated the drug’s potential as a treatment option for rheumatoid arthritis (RA) and psoriatic arthritis (PsA). These studies primarily focused on adult patients whose condition did not adequately respond to initial standard therapies.

Research included randomized, double-blind, placebo-controlled trials (RCTs) to assess potential effects, tolerability, and patient-reported outcomes. The trials typically spanned 6 to 12 months, with some extended observation periods.


Mechanism of Action Studies

Studies evaluated the drug’s mechanism, noting its effect on inhibiting specific cytokine pathways, such as IL-6 and TNF-alpha. These pathways are associated with inflammatory responses.

  • Research has explored whether this targeted action affects the inflammation cycle.
  • Studies examined the drug’s effect on pain, inflammation, and symptoms over time.

Efficacy Findings

Rheumatoid Arthritis (RA)

Clinical trials evaluated the effect on disease activity, as measured by established metrics such as the DAS28 score.

  • A Phase 3 study evaluated the drug in combination with methotrexate (MTX) versus MTX alone in patients with moderate-to-severe active RA.
  • Further research examined the effect on physical function, using patient self-assessment questionnaires.
  • Studies examined the time until a change in effect was observed, with a typical timeframe of 3–5 days reported.

Psoriatic Arthritis (PsA)

Evidence evaluated the use of the drug in treating severe cases, including those with substantial joint damage or significant skin involvement.

  • Clinical trials evaluated the drug combined with physiotherapy, with comparison to placebo on mobility.
  • Research has explored whether the drug has an effect on both joint and skin symptoms associated with PsA. Findings were mixed regarding simultaneous changes in both domains.

Safety and Tolerability

Research included safety and tolerability data for most adult patients. Studies also examined specific populations. The drug’s long-term tolerability was reported in most studies.

  • The most commonly reported side effects in studies included upper respiratory tract infections, headache, and nausea.
  • Research explored whether taking the drug with food affects absorption and its anti-inflammatory effects was a focus of research.
  • For chronic conditions, the drug was examined as a therapeutic option. Researchers continue to follow long-term data.

Key Studies & References

  1. ACR Guideline for the Treatment of Rheumatoid Arthritis
  2. Prednisolone: Summary of Product Characteristics (SPC) - Safety and Tolerability Data

Frequently Asked Questions (FAQ)

Common questions about Deltacortril (FAQ)

Q: Is Deltacortril the same as Prednisone?

A: Deltacortril is a brand name medication, and its active substance is prednisolone. Prednisone is a related drug that the body must convert into prednisolone before it can be active. In oral tablet form, the two medications are often considered to have clinically equivalent effects.

Q: Why is Deltacortril used for so many different conditions?

A: The active ingredient, prednisolone, is classified as a powerful glucocorticoid. According to official sources, this means it has broad actions that combat inflammation and suppress the immune system throughout the body. These widespread effects make it a suitable treatment for managing a wide range of illnesses that involve excessive inflammation or immune activity.

Q: How quickly does Deltacortril start to work for inflammation?

A: Studies and official information indicate that the time until an effect is observed can vary. For certain conditions, clinical trials have reported that a change in effect was typically observed within 3 to 5 days of beginning treatment. The onset of action can depend on the specific condition being managed.

Q: Can Deltacortril cause weight gain?

A: Weight gain is listed in regulatory documents as a common adverse reaction associated with this medication. This is often linked to increased appetite and may also be related to fluid retention within the body.

Q: Is it normal to feel moody or irritable while taking Deltacortril?

A: Official product information notes that behavioral or mood changes are listed as a common adverse reaction to this drug. These changes can include feelings of euphoria, anxiety, or difficulty sleeping (insomnia). In rare instances, more severe psychological effects have been reported.

Q: Can you drink alcohol while taking Deltacortril?

A: Official documents do not typically provide specific guidance on moderate alcohol consumption, but they do warn that the combination may increase the risk of certain side effects, such as stomach irritation or sleep issues.

Q: Does Deltacortril cause withdrawal symptoms when stopped?

A: Official warnings state that abruptly stopping the medication after prolonged therapy is prohibited. This is because sudden cessation can lead to acute adrenocortical insufficiency, a form of withdrawal. For this reason, the treatment schedule requires the dose to be reduced gradually (tapered) when ending therapy.

Q: Is Deltacortril safe for older adults?

A: Official documents indicate that the use of Deltacortril in older adults requires caution and frequent monitoring. This is due to a potentially increased risk of certain side effects in this population compared to younger individuals.

Q: Are there any long-term effects of taking Deltacortril?

A: Yes, official safety information indicates that long-term exposure to the medication is associated with potential effects. These can include a decrease in bone density (osteoporosis), the formation of cataracts, and the development of a Cushingoid state (physical changes due to hormone effects).

Q: Can Deltacortril affect sleep?

A: Insomnia (difficulty falling asleep or staying asleep) is explicitly listed in regulatory documents as a potential common adverse reaction of Deltacortril. If this occurs, it is generally listed as part of the possible behavioral changes associated with the medication.

Q: What is the difference between Deltacortril and Hydrocortisone?

A: Both are classified as corticosteroids, but they differ in their relative potencies according to official pharmacological sources. Prednisolone (Deltacortril’s active ingredient) has a more prominent anti-inflammatory effect compared to hydrocortisone. This difference is due to their varying degrees of effect on the body's mineralocorticoid action (related to salt and water balance).

Q: Is Deltacortril an immunosuppressant?

A: Yes, official product information and classification confirm that Deltacortril functions both as a powerful anti-inflammatory agent and as a systemic immunosuppressant. This dual function is its primary therapeutic purpose.

Q: Are there any specific foods to avoid while on Deltacortril?

A: Official labels generally recommend taking the tablet with or immediately after food or milk to help minimize stomach irritation. There are no general contraindications against specific food types, though official guidance notes that people with conditions like diabetes require careful monitoring of blood sugar while using this medication.

Q: Can Deltacortril be taken on an empty stomach?

A: Official guidance recommends taking the medication with or immediately after food or milk. This is specifically advised to help minimize the risk of gastric irritation or stomach upset that can be associated with the medication.

Q: Why is Deltacortril often prescribed for short periods?

A: Regulatory warnings state that the medication is generally prescribed for the shortest possible time at the lowest effective dose. This protocol is followed because the risk of certain adverse effects, such as the suppression of the body's natural hormone production (HPA axis suppression), increases with prolonged use.

Q: Can children use Deltacortril?

A: Yes, the use of Deltacortril is permitted in pediatric patients. However, official documents state that use requires careful monitoring for specific duration-related risks, including the suppression of growth and bone problems, especially if the treatment is prolonged.

Q: Is Deltacortril used for COVID-19 related inflammation?

A: Authoritative bodies have examined and recommended the use of corticosteroids (including prednisolone) for certain patients. Specifically, corticosteroids have been used to reduce inflammation and immune overstimulation in individuals with severe or critical COVID-19.

Q: Is Deltacortril a brand name or a generic name?

A: Deltacortril is a brand name product. The active ingredient within the tablets, prednisolone, is the generic name for the compound.

Q: Does taking Deltacortril require any special monitoring (like blood tests)?

A: Official regulatory documents advise that certain routine laboratory studies, such as urinalysis, blood sugar determinations, and blood pressure monitoring, are performed at regular intervals during prolonged therapy.

Q: Can Deltacortril make me feel more hungry?

A: Yes, the adverse reaction of increased appetite is listed in official documents, which can lead to a subjective feeling of increased hunger. This effect is also related to the common side effect of weight gain.

Q: What are the main research themes for long-term Deltacortril use?

A: Research themes on long-term use focus on understanding and managing potential risks. Key areas of investigation include the prevention of osteoporosis (bone loss), the long-term risk of serious infections, and the monitoring of adrenal gland suppression that can occur over time.

Q: Is Deltacortril used to manage symptoms of multiple sclerosis?

A: Yes, official medical information indicates that corticosteroids like prednisolone are examined and used to manage acute relapses of Multiple Sclerosis. This is achieved by reducing the inflammation in the central nervous system associated with the relapse event.

Q: Is Deltacortril used in the treatment of asthma?

A: Yes. Due to its potent anti-inflammatory effects, official guidelines indicate that oral corticosteroids like prednisolone are examined and used for moderate to severe asthma exacerbations to help reduce swelling and inflammation in the airways.

Q: Can Deltacortril be used to treat skin conditions?

A: Yes, official sources confirm that the medication's anti-inflammatory properties make it suitable for managing a wide variety of inflammatory skin conditions. These include conditions such as severe eczema and systemic lupus erythematosus.

Q: Can Deltacortril cause stomach upset?

A: While regulatory warnings focus on the serious risk of peptic ulceration, official guidance recommends taking the medicine with food to minimize gastric irritation. This implies that general stomach upset is a potential effect, and steps should be taken to mitigate it.

Q: Is there a maximum dose for Deltacortril described in official sources?

A: Official documents provide a wide range for the initial daily dose but consistently state that the drug is prescribed at the lowest effective dose required for treatment. Doses above a certain threshold (often cited around 40 mg per day) are commonly considered a high dose in medical practice.

Q: Why do official sources sometimes mention 'adrenal suppression' with Deltacortril?

A: Official sources mention this due to the drug's effect on the hypothalamic-pituitary-adrenal (HPA) axis. Prolonged use of glucocorticoids can cause this axis to reduce the body's natural production of the hormone cortisol, leading to a condition known as adrenal suppression.

Q: Can Deltacortril affect my eyesight?

A: Yes, official safety information indicates that long-term use of the medication can lead to the development of cataracts. Additionally, less frequent adverse reactions affecting vision, such as blurred or tunnel vision, have been reported in official documents.

Q: Does Deltacortril cause water retention?

A: Fluid retention is explicitly listed as a common adverse reaction in official regulatory documents. This effect is often related to the mineralocorticoid activity of the drug and can contribute to weight changes.

Q: Can Deltacortril cause changes in mood or personality?

A: Official documents explicitly list mood changes and behavioral changes as adverse reactions. While less common, more severe effects, including noticeable personality changes or psychosis, have also been reported in regulatory safety data.

How should Deltacortril be stored and disposed of?

Storage and Disposal Requirements for Deltacortril (Prednisolone)

Deltacortril (prednisolone) must be stored under specific conditions to maintain its effectiveness. The medication should be stored at a temperature below 25 C and must be protected from moisture and light. It is required to keep the medicine in the original packaging until use.

Child Safety and Disposal

It is mandatory to keep Deltacortril out of the sight and reach of children to prevent accidental ingestion. Do not use the tablets after the expiry date printed on the carton. For disposal, unused or expired medicine must be handled according to local waste regulations. Utilizing a drug take-back program is the preferred method for proper disposal, and the product should generally not be disposed of in household waste or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Deltacortril found in:

A-Z Index: